Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
#4 on Breakout Boards
VOLUMEEEE, yeah baby
Keep up this sort of volume and we could be off to the races!
Well you're right about one thing...it is a leap year.
Nibble, nibble
I don't need to read anything again. I'm very secure in both my position and the company outlook.
Very clear indeed.
Seems many folks on here are being deliberately obtuse.
My god people, give it a rest. Definitive statement from the company:
https://progressivecareus.com/addressing-reverse-split-rumor/
Can we PLEASE move past all this RS nonsense???
Hit the ask a bit this morning. Got some .007's & .008's filled this afternoon.
GLTA
That was kind of them to call the shell a "Pet Product business". Can't wait to be rid of any reminders of that scam...
Definitely liked the PR yesterday, the future is looking bright and the tickets for the BrewBilt show are currently pretty cheap IMO. Looking forward to some financials for sure.
RS is not currently in the conversation...
Perhaps once the PPS reaches a fair valuation and everything else is a GO for uplist to a major exchange. I really don't think they would do anything before then. You're correct though...if the PPS is a fair valuation, ratio would be quite small.
KELSEYVILLE, CA, Dec. 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Vet Online Supply, Inc. (OTC PINK:VTNL) (“Vet Online Supply” or the “Company”), BrewBilt Manufacturing, LLC (a California Limited Liability Corporation) CEO and Chairman, Jef Lewis, states the following:
“On November 22, 2019, we entered into a Merger Agreement between BrewBilt Manufacturing and the Company. Pursuant the 8K Filing on November 22, 2019, the Merger with BrewBilt brings a growing business with revenue of $2M+ and assets to the company and to our shareholders. With new purchase orders of over $1M in process, BrewBilt has been manufacturing quality beer brewing systems since 2014, and manufacturing cannabis systems used for extraction of hemp and CBD during the same period. The global industrial hemp market size is estimated at USD 3.9 billion in 2017, expanding at a CAGR of 14.0% over the forecast period. Growing demand for hemp-based food products including cooking oil, dairy alternatives, flour, and salad dressings is expected to drive market growth. In addition, rising demand for bakery products such as bread and cookies is expected to drive the market.
“Our objective in being a publicly owned company at this time is to broaden our scope of value over the next 5 years as we grow and enter the world market for supplying the growing beer industry and cannabis extraction industry. Our business is not a start-up, and we continue to be recognized as the quality manufacturer for restaurants and small breweries, and for cannabis growers seeking extraction systems for processing hemp and CBD.
“Our auditing firm and accounting firm are preparing the required Super-8K filing consisting of our financials. The audited 10K for the period ending 12/31/2019 will be filed on or before 3/15/2019. The company plans to change its name to ‘BrewBilt Manufacturing’ and receive new trading symbols. The Pet Product business will be spun-off before the end of 2020.
“The future outlook over the next 5 years for our company, based upon our growth rate since 2014, is promising since the hemp seeds segment is likely to expand at a CAGR of 17.1% during the forecast period, in terms of revenue. This growth is attributed to the rising demand for oil, seedcakes, and various food and nutraceutical items. Nutraceutical products are known for their high fatty acid content and nutritional value. Seeds comprise about 35.0% oil, which contains roughly 80.0% essential fatty acids and 20.0% crude protein. BrewBilt manufactures the highest quality products for this industry.”
I'd be thrilled with .25 Gotta get some eyeballs on this ticker!
Name change wouldn't hurt either...
All good in Fidelity
Completely wrong.
Real business with real growth, revenue, and profits.
Really curious to see the action today...
Great response and thanks for posting.
More like Get Ready to Liftoff BIGtime
Feed me those .50's
Thanks for posting, the future is looking brighter than ever!
30% retracement is nothing considering the run-up in the past month
Highly doubtful, lots of technical support @ .50
It was either that or Market Disruptor!
Could easily see .50 on next run.
Last run went from .02 > .26 on 20M revenue figures...now we're looking to double that number only 2 years later.
December performance brings 2019 sales to a close at $32.25 million (up 54% year-over-year) on more than 450,000 prescriptions filled (up 50% year-over-year), with Family Physicians Rx (FPRX) contributing from June 1 through December 31, 2019
Sleeping giant
They should revise the colloquialism to scaredy shorts
Sky is the limit my friend.
Regardless of the outcome, always nice to invest in a company doing some good in the world.
Textbook pennant chart
As Nebula stated earlier,
50DMA @ 0.49
20DMA @ 0.75
Oh yeah...
I'll definitely be wanting those long-term hold taxes if we hit BIG.
On the upside, only 9 more months til it's a long term hold for me...haha
Please don't make me wait that long $CBBT
Sitting tight is getting awfully boring, but I'm holding too.
Love the nervous chatter from the shorts, always a good sign.
More Exposure > More Volume
Easily worth .25+ based on current revenue.
With growth multiple...sky is the limit
Not getting any of mine
Weak day on the big boards and snooze-fest on the OTC. Enjoy the weekend everyone.
Fidelity finally letting me buy $FRLF shares again. Just in time to scoop some cheapies.
Based on a 3-4X revenue valuation, a fair PPS should be 0.22-0.29.
.35 is ~4.8X revenue valuation...certainly not unfair given their growth model
The PPS obviously does not reflect the company's success.
Correlation does not imply causation